Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Earl Sands"'
Autor:
Alan Kivitz, Wesley DeHaan, Rehan Azeem, Justin Park, Sheri Rhodes, Jamie Inshaw, Sheldon S. Leung, Savvas Nicolaou, Lloyd Johnston, Takashi K. Kishimoto, Peter G. Traber, Earl Sands, Hyon Choi
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 4, Pp 825-847 (2023)
Abstract Introduction SEL-212 is a developmental treatment for uncontrolled gout characterized by serum uric acid (sUA) levels ≥ 6 mg/dl despite treatment. It comprises a novel PEGylated uricase (SEL-037; also called pegadricase) co-administered wi
Externí odkaz:
https://doaj.org/article/cf6f1cb3ba274f37b044035ffe0ee7d4
Autor:
Earl Sands, Alan Kivitz, Wesley DeHaan, Sheldon S. Leung, Lloyd Johnston, Takashi Kei Kishimoto
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
Anti-drug antibodies (ADA) induced by biologic drugs may hamper the efficacy of treatment, so inhibiting ADA induction is desirable. Here, in two clinical trials, the authors show that ImmTOR, previously reported to reduce drug immunogenicity in anim
Externí odkaz:
https://doaj.org/article/de97b0524c024b9b8277b1e7a9bd7ca8
Autor:
Alice Robertson, Elizabeth Ofili, Priscilla Pemu, Wendy Painter, April L. Speed, Kiwita Phillips, Earl Sands
Publikováno v:
Journal of Clinical Oncology. 33:99-99
99 Background: Breast cancer patients taking tamoxifen (TAM) or an aromatase inhibitor (AI) often develop severe vasomotor symptoms (VMS) yet the only FDA approved non-hormonal treatment for VMS, 7.5 mg paroxetine, has a warning against concomitant u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d5a4ea66ae0fdb17e589940fd4e3480
https://doi.org/10.1200/jco.2015.33.28_suppl.99
https://doi.org/10.1200/jco.2015.33.28_suppl.99